{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T13:17:17Z","timestamp":1789564637225,"version":"build-2803163510"},"reference-count":20,"publisher":"MDPI AG","issue":"21","license":[{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Cutaneous T-Cell Lymphomas (CTCL) are a heterogenous group of T-cell malignancies in the skin and have poor treatment outcomes in advanced stages. CD5, a surface glycoprotein expressed on most mature T cells, has emerged as a promising target for chimeric antigen receptor (CAR) T-cell therapy in systemic T-cell lymphomas. However, its expression profile in CTCL and relevance for targeted therapy remain unclear. Notably, in CTCL, the cell surface expression of receptors, such as CD7 and CD26, tends to become downregulated on the surfaces of malignant T cells In this study, we analyzed single-cell RNA sequencing (scRNA-seq) data from patients at two institutions with mycosis fungoides (MF), the most common subtype of CTCL with a predominantly CD4 phenotype. We utilized 5 patch\/plaque MF skin biopsies (majority from early-stage patients), 8 MF tumor biopsies (all from advanced-stage patients), and 8 healthy control biopsies to evaluate lesion-specific CD5 gene expression on CD4 T cells. We found that CD5 was significantly increased in malignant MF CD4 T cells compared to healthy control CD4 T cells (21.1% of MF CD4 T cells expressed CD5 vs. 5.2% of healthy control CD4 T cells, respectively). In subgroup analysis, patch\/plaque stage MF biopsies showed higher expression of CD5 in CD4 T cells than tumor stage MF biopsies. Notably, 94.3% of malignant CD4+ T cells in tumor stage MF lesions exhibited complete CD5 loss compared to only 76.6% in patch-plaque MF lesions, suggesting antigen escape in tumor stage disease. These findings demonstrate that CD5 expression in CTCL is dynamic and varies based on lesion type. Our work suggests CD5 may be a viable therapeutic target in MF with patch\/plaque presentations but may not be as effective in advanced stages of MF with tumor presentations. This work informs CD5 gene expression in MF based on clinical lesion type and further information is needed to clarify clinical implications as a future therapeutic target.<\/jats:p>","DOI":"10.3390\/ijms262110411","type":"journal-article","created":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T07:31:58Z","timestamp":1761550318000},"page":"10411","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["CD5 Expression in CTCL and Its Implications for Anti-CD5 CAR T-Cell Therapy"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-1979-9944","authenticated-orcid":false,"given":"Leena","family":"Wardeh","sequence":"first","affiliation":[{"name":"Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, PA 19107, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2065-5682","authenticated-orcid":false,"given":"Madeline","family":"Williams","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, PA 19107, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9314-3403","authenticated-orcid":false,"given":"Courtney","family":"Prestwood","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Emory University, Atlanta, GA 30322, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5034-3173","authenticated-orcid":false,"given":"Zachary","family":"Wolner","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Emory University, Atlanta, GA 30322, USA"},{"name":"Winship Cancer Institute, Emory University, Atlanta, GA 30322, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9587-8689","authenticated-orcid":false,"given":"Neda","family":"Nikbakht","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, PA 19107, USA"},{"name":"Department of Dermatology, Emory University, Atlanta, GA 30322, USA"},{"name":"Department of Hematology and Medical Oncology, Emory University, Atlanta, GA 30322, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood-2018-11-881268","article-title":"The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas","volume":"133","author":"Willemze","year":"2019","journal-title":"Blood"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.cll.2017.06.006","article-title":"Cutaneous T-cell lymphoma","volume":"37","author":"Pulitzer","year":"2017","journal-title":"Clin. Lab. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"205.e1","DOI":"10.1016\/j.jaad.2013.07.049","article-title":"Primary cutaneous T-cell lymphoma (mycosis fungoides and S\u00e9zary syndrome): Part I. Diagnosis: Clinical and histopathologic features and new molecular and biologic markers","volume":"70","author":"Jawed","year":"2014","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e22841","DOI":"10.4161\/onci.22841","article-title":"T-cell modulatory properties of CD5 and its role in antitumor immune responses","volume":"2","author":"Tabbekh","year":"2013","journal-title":"Oncoimmunology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.coi.2011.03.003","article-title":"The immunomodulatory role of CD5 on lymphocyte receptor in health and disease","volume":"23","author":"Soldevila","year":"2011","journal-title":"Curr. Opin. Immunol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Elghawy, O., Cao, M., Xu, J., Landsburg, D.J., Svoboda, J., Nasta, S.D., Chong, E.A., Schuster, S.J., Thomas, C.J., and Carter, J.S. (2024). Prevalence and prognostication of CD5+ mature T-cell lymphomas. Cancers, 16.","DOI":"10.3390\/cancers16193430"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3732","DOI":"10.1182\/blood.2021014468","article-title":"Resistance to mogamulizumab is associated with loss of CCR4 in cutaneous T-cell lymphoma","volume":"139","author":"Beygi","year":"2022","journal-title":"Blood"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"To, V., Evtimov, V.J., Jenkin, G., Pupovac, A., Trounson, A.O., and Boyd, R.L. (2022). CAR-T cell development for cutaneous T cell lymphoma: Current limitations and potential treatment strategies. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.968395"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1182\/blood.2023022204","article-title":"Antitumor efficacy and safety of unedited autologous CD5.CAR T cells in relapsed\/refractory mature T-cell lymphomas","volume":"143","author":"Hill","year":"2024","journal-title":"Blood"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.jid.2021.09.003","article-title":"Exhausted Markers in Cutaneous T-Cell Lymphoma: The Face that Launched a Thousand Ships","volume":"142 Pt A","author":"Jiang","year":"2022","journal-title":"J. Investig. Dermatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41408-021-00459-7","article-title":"CAR-T cell therapy: Current limitations and potential strategies","volume":"11","author":"Sterner","year":"2021","journal-title":"Blood Cancer J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41591-024-03282-2","article-title":"Allogeneic CD5-specific CAR-T therapy for relapsed\/refractory T-ALL: A phase 1 trial","volume":"31","author":"Pan","year":"2025","journal-title":"Nat. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"4443","DOI":"10.1158\/1078-0432.CCR-19-0148","article-title":"Single-cell lymphocyte heterogeneity in advanced cutaneous T-cell lymphoma skin tumors","volume":"25","author":"Gaydosik","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/bjd.20512","article-title":"Single-cell RNA sequencing profiling in a patient with discordant primary cutaneous B-cell and T-cell lymphoma reveals micromilieu-driven immune skewing","volume":"185","author":"Jonak","year":"2021","journal-title":"Br. J. Dermatol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Rindler, K., Bauer, W.M., Jonak, C., Wielscher, M., Shaw, L.E., Rojahn, T.B., Thaler, F.M., Porkert, S., Simonitsch-Klupp, I., and Weninger, W. (2021). Single-cell RNA sequencing reveals tissue compartment-specific plasticity of Mycosis Fungoides tumor cells. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.666935"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s12943-021-01419-2","article-title":"Single-cell RNA sequencing reveals markers of disease progression in primary cutaneous T-cell lymphoma","volume":"20","author":"Rindler","year":"2021","journal-title":"Mol. Cancer"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/bjd\/ljae313","article-title":"Single-cell RNA sequencing comparison of CD4+, CD8+ and T-cell receptor \u03b3\u03b4+ cutaneous T-cell lymphomas reveals subset-specific molecular phenotypes","volume":"192","author":"Chennareddy","year":"2025","journal-title":"Br. J. Dermatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41587-023-01767-y","article-title":"Dictionary learning for integrative, multimodal and scalable single-cell analysis","volume":"42","author":"Hao","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Hafemeister, C., and Satija, R. (2019). Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression. Genome Biol., 20.","DOI":"10.1186\/s13059-019-1874-1"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Choudhary, S., and Satija, R. (2022). Comparison and evaluation of statistical error models for scRNA-seq. Genome Biol., 23.","DOI":"10.1186\/s13059-021-02584-9"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/21\/10411\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T07:32:24Z","timestamp":1761550344000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/21\/10411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,27]]},"references-count":20,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["ijms262110411"],"URL":"https:\/\/doi.org\/10.3390\/ijms262110411","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,27]]}}}